In This Section

Laura A. Hart, MD

Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences

Laura Hart
For Patients
Contact Information

Contact Information


Education, Training & Credentials

Educational Background

  • Fellowship, Maternal Fetal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 2015
  • Internship/Residency, Obstetrics & Gynecology, Drexel University College of Medicine, Hahnemann University Hospital, Philadelphia, PA, 2012
  • MD, St. George's University School of Medicine, Grenada, West Indies, 2008
  • BA, Mount Holyoke College, South Hadley, MA, 2000


  • OB/GYN
  • Maternal Fetal Medicine


  • Texas Medical Association

Referred Original Articles in Journals

George D, Jonasch E, Hart L, et al. A phase I, dose-escalating and pharmacokinetic (PK) study of the VEGF-receptor inhibitor PTK787/ZK 222584 (PTK/ZK) in patients with advanced renal cell or prostate carcinomas. Clin Cancer Res 2001 7:548 (supp)

Hart L, Ober J, Bhattacharya A, Xiong Y, Montgomery O, Jackson L, Geifman-Holtzman O. Maternal plasma as a source for fetal DNA is better than fetal cells for non-invasive prenatal diagnosis of single gene disorders. Gender Medicine 9(1) supp: February 2012

Connealy BD, Carreno CA, Kase BA, Hart LA, Blackwell SC, Sibai BM. A history of prior preeclampsia as a risk factor for preterm birth. Am J Perinatol. 2013 Aug 9. [Epub ahead of print]

Chapters and Invited Reviews.

Plante L, Hart L. Respiratory Diseases: Asthma, Pneumonia, Influenza, and Tuberculosis. Maternal Fetal Medicine: Evidence-Based Guidelines, 2nd Edition; Chapter 24; V Berghella, MD- editor-in-chief; Informa Healthcare; New York, NY; 2011.

Hart L, Sibai BM. Seizures in Pregnancy: Epilepsy, Eclampsia, Stroke. Seminars in Perinatology. 2013 Aug;37(4):207-24.